Journals / Experimental Biomedical Research / 2020 / Cilt: 3 - Sayı: 2

Early graft survival after renal transplantation, single center experience

Pages
71–778
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Because of the number of patients and the short follow-up period, further studies are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The best treatment for patient with end stage kidney disease is kidney transplantation which improve their quality of life and survival rate.
📊
Key Findings & Data:Method: Twenty-eight adult patients who underwent renal transplantation from 2016 to 2017 were included in our university.
💡
Conclusion & Impact:Because of the number of patients and the short follow-up period, further studies are needed.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: The best treatment for patient with end stage kidney disease is kidney transplantation which improve their quality of life and survival rate. The aim of our study is to determine the factors that affect the results of early outcomes of graft function. Method: Twenty-eight adult patients who underwent renal transplantation from 2016 to 2017 were included in our university. Results: The median age of the recipients was 38.5 (range: 19-65) and 68% (19 patients) were male. Acute rejection was detected in 8 patients. Patients who developed rejection were found to have higher panel reactive antibody positivity and higher parathyroid hormone levels. Panel reactive antibody positivity was found to be 25% in patients who developed rejection and 0% in patients who did not develop rejection (p = 0.02). The parathyroid hormone level was calculated as 963.2 ± 587 in the rejection group and 378 ± 227 in the rejection group (p = 0.003). It was observed that 37.5% of DM patients had rejection and 10% in non-diabetic patients. The difference was statistically significant (p = 0.08). Conclusion: Panel reactive antibody positivity and parathyroid hormone levels increased the likelihood of rejection. The effect of the presence of diabetes mellitus in the patient on the development of rejection was observed to be limited. Our findings were consistent with the literature. Because of the number of patients and the short follow-up period, further studies are needed.

🔖

Cite This Article

BEYLER, Ö., ÖZEN, M. C., ERGÜN, İ. (2020). Early graft survival after renal transplantation, single center experience. Experimental Biomedical Research, Cilt: 3 - Sayı: 2, 71–778. https://ajindex.com/articles/156988

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000
  2. 342(9):605-12. [2]Pham PT, Pham PA, Pham PC, et al. Evaluation of adult kidney transplant candidates. Seminars in dialysis
  3. Wiley Online Library. Available from: https://doi.org/10.1111/j.1525- 139X.2010.00809.x [3]Erdbruegger U, Scheffner I, Mengel M, et al. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transplant. 2012
  4. 27(1):435-43. [4]Moore J, McKnight AJ, Simmonds MJ, et al. Association of caveolin-1 gene polymorphism with kidney transplant fibrosis and allograft failure. JAMA. 2010
  5. 303(13):1282-87. [5]Winkelmayer WC, Kramar R, Curhan GC, et al. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. Nephrol Dial Transplant. 2006
  6. 21(12):3559-66. [6]Djamali A, Samaniego M, Muth B, et al. Medical Care of Kidney Transplant Recipients after the First Posttransplant Year. Clin J Am Soc Nephrol. 2006
  7. 1(4):623-40. [7]Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002
  8. 73(1):70-74. [8]Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renaltransplant survival. Lancet. 2001
  9. 357(9270):1758-61. [9]Massy ZA, Guijarro C, Kasiske BL. Clinical predictors of chronic renal allograft rejection. Kidney Int Suppl. 1995
  10. S85-8. [10]Paul LC, Benediktsson H. Post-transplant hypertension and chronic renal allograft failure. Kidney Int Suppl. 1995
  11. S34–S37. [11]Scornik J, Meier‐Kriesche HU. Blood transfusions in organ transplant patients: mechanisms of sensitization and implications for prevention. Am J Transplant. 2011
  12. 11(9):1785-91. [12]Obrador GT, Macdougall IC. Effect of red cell transfusions on future kidney transplantation. Clin J Am Soc Nephrol. 2013
  13. 8(5):852-60. [13]Ashraf HS, Hussain I, Siddiqui AA, et al. The outcome of living related kidney transplantation with multiple renal arteries. Saudi J Kidney Dis Transpl. 2013
  14. Wu C, Shapiro R, Tan H, et al. Kidney transplantation in elderly people: the influence of recipient comorbidity and living kidney donors. J Am Geriatr Soc. 2008
  15. 56(2):231-38. [15]Englum BR, Schechter MA, Irish W